Financhill
Sell
40

ELVN Quote, Financials, Valuation and Earnings

Last price:
$43.19
Seasonality move :
9.15%
Day range:
$38.76 - $43.35
52-week range:
$13.30 - $43.35
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.23x
Volume:
3.1M
Avg. volume:
1.4M
1-year change:
141.52%
Market cap:
$2.9B
Revenue:
--
EPS (TTM):
-$1.86

Earnings Data

Next earnings date for ELVN
May 13
2026
Most recent earnings per share
-$0.48
Missed by $0.00
(Mar 3/2026)
Consensus Estimate
-$0.48
(Mar 3/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ELVN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2026 Q2 -- -- -- -$0.42 --
05/13/2026 Q1 -- -- -- -$0.41 --
03/03/2026 Q4 $10K -- -$0.48 -$0.48 -$0.00
11/12/2025 Q3 -- -- -$0.32 -$0.47 $0.14
08/13/2025 Q2 -- -- -$0.49 -$0.42 -$0.07
05/15/2025 Q1 -- -- -$0.57 -- --
03/13/2025 Q4 -- -- -$0.46 -- --
11/13/2024 Q3 -- -- -$0.48 -$0.50 $0.02
08/13/2024 Q2 -- -- -$0.42 -- --
05/14/2024 Q1 -- -- -$0.54 -- --
03/14/2024 Q4 -- -- -$0.47 -- --
11/09/2023 Q3 -- -- -$0.51 -- --
08/10/2023 Q2 -- -- -$0.41 -- --
05/11/2023 Q1 -- -- -$0.80 -- --
12/31/2022 Q4 -- -- $4.90 -- --
09/30/2022 Q3 -- -- -$3.27 -- --
06/30/2022 Q2 -- -- -$2.86 -- --
03/31/2022 Q1 -- -- -$3.01 -- --
12/31/2021 Q4 -- -- -$2.18 -- --
09/30/2021 Q3 -- -- -$2.19 -- --
06/30/2021 Q2 -- -- -$2.97 -- --
03/31/2021 Q1 -- -- -$2.33 -- --
12/31/2020 Q4 -- -- -$2.63 -- --
09/30/2020 Q3 -- -- -$2.86 -- --
06/30/2020 Q2 -- -- -$2.37 -- --
03/31/2020 Q1 -- -- -$3.64 -- --
12/31/2019 Q4 -- -- -$1.68 -- --
09/30/2019 Q3 -- -- -$1.53 -- --

Enliven Therapeutics, Inc. Earnings Questions

  • How Much did Enliven Therapeutics, Inc. Generate in Revenue Last Quarter?

    Enliven Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Enliven Therapeutics, Inc. Beat Earnings Last Quarter?

    Enliven Therapeutics, Inc. announced earnings per share of -$0.48 which represents a miss of analyst forecast a -$0.48 per share.

  • Is Enliven Therapeutics, Inc. Profitable?

    Enliven Therapeutics, Inc. reported -$46K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Enliven Therapeutics, Inc. EPS Next Year?

    Enliven Therapeutics, Inc.'s earnings are forecast to decrease from -$1.83 per share to -$1.80 per share next year representing a decrease of -6.01%.

  • When is Enliven Therapeutics, Inc.'s Earnings Date?

    Enliven Therapeutics, Inc.'s next earnings date is May 13, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
46
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
42
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Buy
51
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
75
CAR alert for Apr 8

Avis Budget Group, Inc. [CAR] is up 20.18% over the past day.

Buy
100
BETR alert for Apr 8

Better Home & Finance Holding Co. [BETR] is up 11.22% over the past day.

Sell
40
ELVN alert for Apr 8

Enliven Therapeutics, Inc. [ELVN] is up 10.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock